James Glasbey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
James Glasbey has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- James Edward Frankland Fitzgerald
Association of Surgeons in Training, 35-43 Lincoln's Inn Fields, London, WC2A 3PE, UK
17 shared publications Dmitri Nepogodiev
Surgical Data Institute, Institute of Translational Medicine, University of Birmingham, Birmingham, UK
16 shared publications- Rhiannon L. Harries
Association of Surgeons in Training, 35-43 Lincoln's Inn Fields, Holborn, London, WC2A 3PE, UK
16 shared publications Aneel Bhangu
Surgical Data Institute, Institute of Translational Medicine, University of Birmingham, Birmingham, UK
15 shared publications- Stephen J. Chapman
Leeds Institute of Medical Research, University of Leeds , Leeds
13 shared publications - Chetan Khatri
Clinical Trials Unit, University of Warwick, Coventry, UK
11 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by Springer Nature in Trials
Long-term participant-reported outcomes after the GeneRAtiNg StUdent recruiters for randomised triaLs (GRANULE) course: a longitudinal, survey-based, international cohort study
Background: Patient recruitment into clinical trials remains a major challenge and recruitment consultations play a key role in a patient’s decision to provide their informed consent. Currently, training in this important skill is absent from medical school and training curricula. This study aimed to evaluate the long-term participant-reported outcomes of a training course for medical students and junior doctors to provide information and informed consent for trial randomisation and recruitment. Methods: The ‘GeneRAtiNg StUdent recruiters for randomised triaLs’ (GRANULE) course provides practical, evidence-based skills in conveying equipoise, balancing treatment options, and explaining randomisation during a trial recruitment consultation. Attendees were asked to complete a survey about their understanding of key concepts and experience in trial recruitment at two timepoints: (1) immediately after the course and (2) greater than 1 year after course completion. The survey asked for views about attendees’ confidence in communicating equipoise, randomisation, exploring patient preferences, and gaining consent in clinical trials. Response categories utilised five-point Likert scales. Paired t -tests were used to explore associations between survey responses. We also explored participants’ reported perceptions of the course’s relevance to their personal and professional development using open-ended questions. Data were coded and interpreted through thematic content analysis. Results: Between 2016 and 2020, eight face-to-face courses were delivered in four countries to 98 medical students and junior doctors from 11 countries. The questionnaire response rate on long-term follow-up was 59.1% ( n = 58/98); median follow-up of 3.0 years (IQR: 2.0 to 4.0). Confidence in gaining (mean difference: −0.19, 95% CI: −0.45 to 0.078, p = 0.16) and documenting valid consent for trial involvement (mean difference: −0.063, 95% CI: −0.46 to 0.34, p = 0.75) was maintained on follow-up, while there were small reductions in respondents’ reported confidence in conveying clinical equipoise (mean difference: −0.53, 95% CI: −0.83 to −0.23, p = 0.001) over time. Over a third of respondents (36.2%, n = 21/58) had been involved in clinical trials since attending the course, 81.0% ( n = 17/21) of whom had experience of recruitment (median: 10.0 patients recruited, IQR: 3.0 to 24.0). Conclusions: Among follow-up respondents, the GRANULE course was associated with sustained participant-reported confidence in several trial recruitment domains and substantial subsequent involvement in clinical trials. Structured recruiter training may help address an important gap in medical curricula, although comparator-based studies are needed to determine causal effects.
- 14 October 2026
- Published by Springer Nature in Trials
Open AccessLong-term participant-reported outcomes after the GeneRAtiNg StUdent recruiters for randomised triaLs (GRANULE) course: a longitudinal, survey-based, international cohort study
Background: Patient recruitment into clinical trials remains a major challenge and recruitment consultations play a key role in a patient’s decision to provide their informed consent. Currently, training in this important skill is absent from medical school and training curricula. This study aimed to evaluate the long-term participant-reported outcomes of a training course for medical students and junior doctors to provide information and informed consent for trial randomisation and recruitment. Methods: The ‘GeneRAtiNg StUdent recruiters for randomised triaLs’ (GRANULE) course provides practical, evidence-based skills in conveying equipoise, balancing treatment options, and explaining randomisation during a trial recruitment consultation. Attendees were asked to complete a survey about their understanding of key concepts and experience in trial recruitment at two timepoints: (1) immediately after the course and (2) greater than 1 year after course completion. The survey asked for views about attendees’ confidence in communicating equipoise, randomisation, exploring patient preferences, and gaining consent in clinical trials. Response categories utilised five-point Likert scales. Paired t -tests were used to explore associations between survey responses. We also explored participants’ reported perceptions of the course’s relevance to their personal and professional development using open-ended questions. Data were coded and interpreted through thematic content analysis. Results: Between 2016 and 2020, eight face-to-face courses were delivered in four countries to 98 medical students and junior doctors from 11 countries. The questionnaire response rate on long-term follow-up was 59.1% ( n = 58/98); median follow-up of 3.0 years (IQR: 2.0 to 4.0). Confidence in gaining (mean difference: −0.19, 95% CI: −0.45 to 0.078, p = 0.16) and documenting valid consent for trial involvement (mean difference: −0.063, 95% CI: −0.46 to 0.34, p = 0.75) was maintained on follow-up, while there were small reductions in respondents’ reported confidence in conveying clinical equipoise (mean difference: −0.53, 95% CI: −0.83 to −0.23, p = 0.001) over time. Over a third of respondents (36.2%, n = 21/58) had been involved in clinical trials since attending the course, 81.0% ( n = 17/21) of whom had experience of recruitment (median: 10.0 patients recruited, IQR: 3.0 to 24.0). Conclusions: Among follow-up respondents, the GRANULE course was associated with sustained participant-reported confidence in several trial recruitment domains and substantial subsequent involvement in clinical trials. Structured recruiter training may help address an important gap in medical curricula, although comparator-based studies are needed to determine causal effects.
- Open Access
- 16 July 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (7) , e022894
Catastrophic health expenditures associated with single admission for paediatric surgery in a low-resource setting: a multicentre study
Background: Catastrophic healthcare expenditure (CHE) poses significant financial burdens on households globally, particularly in low- and middle-income countries. This study was designed to determine the prevalence of CHE among families of paediatric surgical patients admitted for surgery and to explore factors associated with it. Methods: The study was a prospective, multicentre, cross-sectional study carried out in 25 hospitals with paediatric surgery in Nigeria from July to November 2024. Consecutive patients below 16 years of age who underwent surgery were included. CHE was defined as health expenditure above 10% of the head of household annual household income. Data on demographic data, educational and employment status of parents and other related factors were collected and analysed using Stata. Results: A total of 1665 patients were recruited with ages ranging from 5 days to ≤16 years (median=4.74 years). Overall median annual income for the heads of household was US$1097.78. The median (IQR) cost of care was US$129.81 per patient and 56.3% of households spent out of pocket and only 11.7% of households had access to health insurance. A total of 981 households (58.9%; 95% CI 56.5% to 61.3%) experienced CHE. The CHE incidence rate ratio (IRR) decreased among households where the patients were male (IRR 0.92 (95% CI 0.86 to 0.98); p=0.011), the head-of-households had a graduate/postgraduate education (IRR 0.64 (95% CI 0.53 to 0.78); p<0.001), but increased when major surgery was performed (IRR 1.25 (95% CI 1.08 to 1.44); p=0.002) and with prolonged hospital stay (1.008 (95% CI 1.005 to 1.011); p<0.001). The main sources of funds for healthcare were out-of-pocket (n=936, 56.3%) and availability of health insurance was significant in preventing CHE, as three of every four households accessing health insurance did not experience it. Conclusion: Catastrophic health expenditure was highly prevalent among families of children who underwent surgery in Nigeria, particularly among those who had major and emergency surgeries.
- 16 July 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (7) , e022894
Open AccessCatastrophic health expenditures associated with single admission for paediatric surgery in a low-resource setting: a multicentre study
Background: Catastrophic healthcare expenditure (CHE) poses significant financial burdens on households globally, particularly in low- and middle-income countries. This study was designed to determine the prevalence of CHE among families of paediatric surgical patients admitted for surgery and to explore factors associated with it. Methods: The study was a prospective, multicentre, cross-sectional study carried out in 25 hospitals with paediatric surgery in Nigeria from July to November 2024. Consecutive patients below 16 years of age who underwent surgery were included. CHE was defined as health expenditure above 10% of the head of household annual household income. Data on demographic data, educational and employment status of parents and other related factors were collected and analysed using Stata. Results: A total of 1665 patients were recruited with ages ranging from 5 days to ≤16 years (median=4.74 years). Overall median annual income for the heads of household was US$1097.78. The median (IQR) cost of care was US$129.81 per patient and 56.3% of households spent out of pocket and only 11.7% of households had access to health insurance. A total of 981 households (58.9%; 95% CI 56.5% to 61.3%) experienced CHE. The CHE incidence rate ratio (IRR) decreased among households where the patients were male (IRR 0.92 (95% CI 0.86 to 0.98); p=0.011), the head-of-households had a graduate/postgraduate education (IRR 0.64 (95% CI 0.53 to 0.78); p<0.001), but increased when major surgery was performed (IRR 1.25 (95% CI 1.08 to 1.44); p=0.002) and with prolonged hospital stay (1.008 (95% CI 1.005 to 1.011); p<0.001). The main sources of funds for healthcare were out-of-pocket (n=936, 56.3%) and availability of health insurance was significant in preventing CHE, as three of every four households accessing health insurance did not experience it. Conclusion: Catastrophic health expenditure was highly prevalent among families of children who underwent surgery in Nigeria, particularly among those who had major and emergency surgeries.
- Open Access
- 15 October 2025
- Published by Elsevier in The Lancet Global Health
- Vol. 13 (11) , e1782-e1783
Shifting from epidemiology to intervention to reduce the global burden of death after trauma laparotomy
- 15 October 2025
- Published by Elsevier in The Lancet Global Health
- Vol. 13 (11) , e1782-e1783
Open AccessShifting from epidemiology to intervention to reduce the global burden of death after trauma laparotomy
- 7 October 2025
- Published by Wiley in Colorectal Disease
- Vol. 27 (10) , e70245
Results of the international audit for faecal incontinence on behalf of the European Society of Coloproctology (ESCP) collaborating group
Aim: The aim of this study was to evaluate the prevalence of faecal incontinence (FI) among patients attending colorectal clinics in a global setting, treatment choices and accessibility to diagnostic and treatment tools. Methods: An international, prospective, multi‐centre snapshot audit and survey of patients undergoing consultation regarding FI was undertaken from January 9 to February 28, 2023. Participating units included patients in the audit who presented until March 28, 2023. Main outcomes measured included the prevalence of FI in clinical practice, diagnostic approaches, treatment patterns and availability of interventions. Results: A total of 1853 outpatients with FI and 363 surgical patients were included, representing a prevalence of 6.3% of total clinic attendance over the same period. The majority of patients were female (75.3%), parous (85% of females). Patients presented with passive and urge incontinence, or both, in fairly even proportions (34.8 vs. 29.4 vs. 33.7%, respectively). Aetiology was most commonly anal injury (surgical or obstetric: 15.4% vs. 19.8%, respectively), but with significant proportions of other surgical conditions, such as low anterior resection syndrome (11.1%) and rectal prolapse (12.7%). In the surgical audit ( n = 363), the majority of patients had received previous treatment (61.1%), including pelvic floor physiotherapy (67.1%), bowel retraining with biofeedback (51.4%), and nurse‐led continence support (40.5%). Of 395 procedures performed, sacral neuromodulation was the most common (28.9%), followed by sphincteroplasty (22.0%). In the global practice survey ( n = 250 respondents), endoanal ultrasound (EAUS) (82.4%) and anorectal manometry (74.4%) were the most available diagnostic tools. Conclusions: Globally, FI forms a significant part of colorectal surgeons' clinical workload, with a skew toward structural causes of FI. Practice varies according to the availability of diagnostics and procedures.
- 7 October 2025
- Published by Wiley in Colorectal Disease
- Vol. 27 (10) , e70245
Results of the international audit for faecal incontinence on behalf of the European Society of Coloproctology (ESCP) collaborating group
Aim: The aim of this study was to evaluate the prevalence of faecal incontinence (FI) among patients attending colorectal clinics in a global setting, treatment choices and accessibility to diagnostic and treatment tools. Methods: An international, prospective, multi‐centre snapshot audit and survey of patients undergoing consultation regarding FI was undertaken from January 9 to February 28, 2023. Participating units included patients in the audit who presented until March 28, 2023. Main outcomes measured included the prevalence of FI in clinical practice, diagnostic approaches, treatment patterns and availability of interventions. Results: A total of 1853 outpatients with FI and 363 surgical patients were included, representing a prevalence of 6.3% of total clinic attendance over the same period. The majority of patients were female (75.3%), parous (85% of females). Patients presented with passive and urge incontinence, or both, in fairly even proportions (34.8 vs. 29.4 vs. 33.7%, respectively). Aetiology was most commonly anal injury (surgical or obstetric: 15.4% vs. 19.8%, respectively), but with significant proportions of other surgical conditions, such as low anterior resection syndrome (11.1%) and rectal prolapse (12.7%). In the surgical audit ( n = 363), the majority of patients had received previous treatment (61.1%), including pelvic floor physiotherapy (67.1%), bowel retraining with biofeedback (51.4%), and nurse‐led continence support (40.5%). Of 395 procedures performed, sacral neuromodulation was the most common (28.9%), followed by sphincteroplasty (22.0%). In the global practice survey ( n = 250 respondents), endoanal ultrasound (EAUS) (82.4%) and anorectal manometry (74.4%) were the most available diagnostic tools. Conclusions: Globally, FI forms a significant part of colorectal surgeons' clinical workload, with a skew toward structural causes of FI. Practice varies according to the availability of diagnostics and procedures.
- Open Access
- 4 July 2025
- Published by Springer Nature in Perioperative Medicine
- Vol. 14 (1) , 1-10
Platform trials—an emerging methodology for perioperative medicine: a narrative review
The traditional model for testing new treatments, before widespread usage in clinical practice, is the parallel group randomised trial. However, these are often inefficient, time-consuming and expensive, which can be barriers to the timely improvement of clinical care. This is a particular issue for anaesthesia and perioperative medicine where funding for large clinical trials is often scarce. Platform trials are an emerging methodology for testing new interventions, which offer benefits over the traditional parallel group paradigm. Platform trials have the ability to test multiple interventions at the same time, and to add or remove interventions during the course of the programme without undermining the validity or integrity of the trial findings. They are most often structured around a master protocol, which describes the core methods and research governance processes, with each intervention described in either a sub-section or appendix to the master protocol. The principal benefit to researchers and to research funders is that, unlike the sequential parallel group trial model, platform trials can use the same research infrastructure (e.g. database, standard operating procedures etc.) to answer multiple research questions, which is much more time and cost effective. The benefits of platform trials can be further enhanced with the use of adaptive designs or by sharing control patients, for example, by using a multi-arm multi-stage design. Perioperative medicine, anaesthesia and surgery are ideally placed to benefit from platform trials.
- 4 July 2025
- Published by Springer Nature in Perioperative Medicine
- Vol. 14 (1) , 1-10
Open AccessPlatform trials—an emerging methodology for perioperative medicine: a narrative review
The traditional model for testing new treatments, before widespread usage in clinical practice, is the parallel group randomised trial. However, these are often inefficient, time-consuming and expensive, which can be barriers to the timely improvement of clinical care. This is a particular issue for anaesthesia and perioperative medicine where funding for large clinical trials is often scarce. Platform trials are an emerging methodology for testing new interventions, which offer benefits over the traditional parallel group paradigm. Platform trials have the ability to test multiple interventions at the same time, and to add or remove interventions during the course of the programme without undermining the validity or integrity of the trial findings. They are most often structured around a master protocol, which describes the core methods and research governance processes, with each intervention described in either a sub-section or appendix to the master protocol. The principal benefit to researchers and to research funders is that, unlike the sequential parallel group trial model, platform trials can use the same research infrastructure (e.g. database, standard operating procedures etc.) to answer multiple research questions, which is much more time and cost effective. The benefits of platform trials can be further enhanced with the use of adaptive designs or by sharing control patients, for example, by using a multi-arm multi-stage design. Perioperative medicine, anaesthesia and surgery are ideally placed to benefit from platform trials.
- Open Access
- 19 December 2024
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 134 (2) , 259-262
Global collaboration between platform trials in surgery and anaesthesia
- 19 December 2024
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 134 (2) , 259-262
Open AccessGlobal collaboration between platform trials in surgery and anaesthesia
- Open Access
- 27 November 2024
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 111 (12)
Global collaboration between platform trials in surgery and anaesthesia
Summary: Large, randomized trials are the bedrock of evidence-based medicine, but the resources required to complete such trials greatly limit the number of important clinical questions that can be addressed within a reasonable period of time. Adaptive platform trials can identify effective, ineffective, or harmful treatments faster. These trials have been shown to deliver rapid evidence through the COVID-19 pandemic and are now being adopted across surgery and anaesthesia, with many opportunities for surgeons, anaesthetists, and other perioperative physicians to conduct and collaborate in platform trials.
- 27 November 2024
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 111 (12)
Open AccessGlobal collaboration between platform trials in surgery and anaesthesia
Summary: Large, randomized trials are the bedrock of evidence-based medicine, but the resources required to complete such trials greatly limit the number of important clinical questions that can be addressed within a reasonable period of time. Adaptive platform trials can identify effective, ineffective, or harmful treatments faster. These trials have been shown to deliver rapid evidence through the COVID-19 pandemic and are now being adopted across surgery and anaesthesia, with many opportunities for surgeons, anaesthetists, and other perioperative physicians to conduct and collaborate in platform trials.
- Open Access
- 7 November 2024
- Published by BMJ in BMJ Global Health
- Vol. 9 (Suppl 4) , e015280
Building resilient surgical systems that can withstand external shocks
When surgical systems fail, there is the major collateral impact on patients, society and economies. While short-term impact on patient outcomes during periods of high system stress is easy to measure, the long-term repercussions of global crises are harder to quantify and require modelling studies with inherent uncertainty. When external stressors such as high-threat infectious disease, forced migration or climate-change-related events occur, there is a resulting surge in healthcare demand. This, directly and indirectly, affects perioperative pathways, increasing pressure on emergency, critical and operative care areas. While different stressors have different effects on healthcare systems, they share the common feature of exposing the weakest areas, at which point care pathways breakdown. Surgery has been identified as a highly vulnerable area for early failure. Despite efforts by the WHO to improve preparedness in the wake of the SARS-CoV-2 pandemic, measurement of healthcare investment and surgical preparedness metrics suggests that surgical care is not yet being prioritised by policy-makers. Investment in the ‘response’ phase of health system recovery without investment in the ‘readiness’ phase will not mitigate long-term health effects for patients as new stressors arise. This analysis aims to explore how surgical preparedness can be measured, identify emerging threats and explore their potential impact on surgical services. Finally, it aims to highlight the role of high-quality research in developing resilient surgical systems.
- 7 November 2024
- Published by BMJ in BMJ Global Health
- Vol. 9 (Suppl 4) , e015280
Open AccessBuilding resilient surgical systems that can withstand external shocks
When surgical systems fail, there is the major collateral impact on patients, society and economies. While short-term impact on patient outcomes during periods of high system stress is easy to measure, the long-term repercussions of global crises are harder to quantify and require modelling studies with inherent uncertainty. When external stressors such as high-threat infectious disease, forced migration or climate-change-related events occur, there is a resulting surge in healthcare demand. This, directly and indirectly, affects perioperative pathways, increasing pressure on emergency, critical and operative care areas. While different stressors have different effects on healthcare systems, they share the common feature of exposing the weakest areas, at which point care pathways breakdown. Surgery has been identified as a highly vulnerable area for early failure. Despite efforts by the WHO to improve preparedness in the wake of the SARS-CoV-2 pandemic, measurement of healthcare investment and surgical preparedness metrics suggests that surgical care is not yet being prioritised by policy-makers. Investment in the ‘response’ phase of health system recovery without investment in the ‘readiness’ phase will not mitigate long-term health effects for patients as new stressors arise. This analysis aims to explore how surgical preparedness can be measured, identify emerging threats and explore their potential impact on surgical services. Finally, it aims to highlight the role of high-quality research in developing resilient surgical systems.
- Open Access
- 1 March 2024
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 8 (2)
Non-pharmacological interventions to improve sleep quality and quantity for hospitalized adult patients—co-produced study with surgical patient partners: systematic review
Background: Hospitalized patients experience sleep disruption with consequential physiological and psychological effects. Surgical patients are particularly at risk due to surgical stress and postoperative pain. This systematic review aimed to identify non-pharmacological interventions for improving sleep and exploring their effects on sleep-related and clinical outcomes. Methods: A systematic literature search was performed in accordance with PRISMA guidelines and was preregistered on the Open Science Framework (doi: 10.17605/OSF.IO/EA6BN) and last updated in November 2023. Studies that evaluated non-pharmacological interventions for hospitalized, adult patients were included. Thematic content analysis was performed to identify hypothesized mechanisms of action and modes of administration, in collaboration with a patient partner. Risk of bias assessment was performed using the Cochrane Risk Of Bias (ROB) or Risk Of Bias In Non-Randomized Studies – of Interventions (ROBINS-I) tools. Results: A total of 59 eligible studies and data from 14 035 patients were included; 28 (47.5%) were randomized trials and 26 included surgical patients (10 trials). Thirteen unique non-pharmacological interventions were identified, 17 sleep measures and 7 linked health-related outcomes. Thematic analysis revealed two major themes for improving sleep in hospital inpatients: enhancing the sleep environment and utilizing relaxation and mindfulness techniques. Two methods of administration, self-administered and carer-administered, were identified. Environmental interventions, such as physical aids, and relaxation interventions, including aromatherapy, showed benefits to sleep measures. There was a lack of standardized sleep measurement and an overall moderate to high risk of bias across all studies. Conclusions: This systematic review has identified several sleep interventions that are likely to benefit adult surgical patients, but there remains a lack of high-quality evidence to support their routine implementation.
- 1 March 2024
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 8 (2)
Open AccessNon-pharmacological interventions to improve sleep quality and quantity for hospitalized adult patients—co-produced study with surgical patient partners: systematic review
Background: Hospitalized patients experience sleep disruption with consequential physiological and psychological effects. Surgical patients are particularly at risk due to surgical stress and postoperative pain. This systematic review aimed to identify non-pharmacological interventions for improving sleep and exploring their effects on sleep-related and clinical outcomes. Methods: A systematic literature search was performed in accordance with PRISMA guidelines and was preregistered on the Open Science Framework (doi: 10.17605/OSF.IO/EA6BN) and last updated in November 2023. Studies that evaluated non-pharmacological interventions for hospitalized, adult patients were included. Thematic content analysis was performed to identify hypothesized mechanisms of action and modes of administration, in collaboration with a patient partner. Risk of bias assessment was performed using the Cochrane Risk Of Bias (ROB) or Risk Of Bias In Non-Randomized Studies – of Interventions (ROBINS-I) tools. Results: A total of 59 eligible studies and data from 14 035 patients were included; 28 (47.5%) were randomized trials and 26 included surgical patients (10 trials). Thirteen unique non-pharmacological interventions were identified, 17 sleep measures and 7 linked health-related outcomes. Thematic analysis revealed two major themes for improving sleep in hospital inpatients: enhancing the sleep environment and utilizing relaxation and mindfulness techniques. Two methods of administration, self-administered and carer-administered, were identified. Environmental interventions, such as physical aids, and relaxation interventions, including aromatherapy, showed benefits to sleep measures. There was a lack of standardized sleep measurement and an overall moderate to high risk of bias across all studies. Conclusions: This systematic review has identified several sleep interventions that are likely to benefit adult surgical patients, but there remains a lack of high-quality evidence to support their routine implementation.